Sign in
4

Changes in Ownership

Prime Medicine, Inc. Filed Acc 0001894562-25-000002

Options or other derivatives

  • Chief Financial Officer acquired 275,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Reine Allan Chief Financial Officer 2025-02-27 Grant or award · Stock Option (right to buy) +275,000 275,000 D
Loading xslF345X05/wk-form4_1741050667.xml…